PubMed:32031570 / 1985-2212 JSONTXT

{"project":"LitCovid-OGER-BB","denotations":[{"id":"T8","span":{"begin":42,"end":53},"obj":"CHEBI:7798"},{"id":"T9","span":{"begin":42,"end":53},"obj":"CHEBI:7798"},{"id":"T10","span":{"begin":110,"end":122},"obj":"CHEBI:63611"},{"id":"T11","span":{"begin":110,"end":122},"obj":"CHEBI:63611"},{"id":"T12","span":{"begin":136,"end":147},"obj":"CHEBI:29007"},{"id":"T13","span":{"begin":136,"end":147},"obj":"CHEBI:29007"},{"id":"T14","span":{"begin":161,"end":173},"obj":"CHEBI:2955"},{"id":"T15","span":{"begin":161,"end":173},"obj":"CHEBI:2955"},{"id":"T16","span":{"begin":161,"end":173},"obj":"DG_6"},{"id":"T17","span":{"begin":191,"end":205},"obj":"CHEBI:24261"},{"id":"T18","span":{"begin":191,"end":205},"obj":"CHEBI:24261"}],"namespaces":[{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"}],"text":"Most patients received antiviral therapy (oseltamivir, 124 [89.9%]), and many received antibacterial therapy (moxifloxacin, 89 [64.4%]; ceftriaxone, 34 [24.6%]; azithromycin, 25 [18.1%]) and glucocorticoid therapy (62 [44.9%])."}

{"project":"LitCovid-PAS-Enju","denotations":[{"id":"EnjuParser_T360","span":{"begin":0,"end":4},"obj":"JJS"},{"id":"EnjuParser_T361","span":{"begin":5,"end":13},"obj":"NNS"},{"id":"EnjuParser_T362","span":{"begin":14,"end":22},"obj":"VBD"},{"id":"EnjuParser_T363","span":{"begin":23,"end":32},"obj":"JJ"},{"id":"EnjuParser_T364","span":{"begin":33,"end":40},"obj":"NN"},{"id":"EnjuParser_T365","span":{"begin":41,"end":42},"obj":"-LRB-"},{"id":"EnjuParser_T366","span":{"begin":42,"end":53},"obj":"NN"},{"id":"EnjuParser_T367","span":{"begin":53,"end":54},"obj":"-COMMA-"},{"id":"EnjuParser_T368","span":{"begin":55,"end":58},"obj":"CD"},{"id":"EnjuParser_T369","span":{"begin":59,"end":60},"obj":"-LRB-"},{"id":"EnjuParser_T370","span":{"begin":60,"end":64},"obj":"CD"},{"id":"EnjuParser_T371","span":{"begin":64,"end":65},"obj":"NN"},{"id":"EnjuParser_T372","span":{"begin":65,"end":66},"obj":"-RRB-"},{"id":"EnjuParser_T373","span":{"begin":66,"end":67},"obj":"-RRB-"},{"id":"EnjuParser_T374","span":{"begin":67,"end":68},"obj":"-COMMA-"},{"id":"EnjuParser_T375","span":{"begin":69,"end":72},"obj":"CC"},{"id":"EnjuParser_T376","span":{"begin":73,"end":77},"obj":"JJ"},{"id":"EnjuParser_T377","span":{"begin":78,"end":86},"obj":"VBD"},{"id":"EnjuParser_T378","span":{"begin":87,"end":100},"obj":"JJ"},{"id":"EnjuParser_T379","span":{"begin":101,"end":108},"obj":"NN"},{"id":"EnjuParser_T380","span":{"begin":109,"end":110},"obj":"-LRB-"},{"id":"EnjuParser_T381","span":{"begin":110,"end":122},"obj":"NN"},{"id":"EnjuParser_T382","span":{"begin":122,"end":123},"obj":"-COMMA-"},{"id":"EnjuParser_T383","span":{"begin":124,"end":126},"obj":"CD"},{"id":"EnjuParser_T384","span":{"begin":127,"end":128},"obj":"-LRB-"},{"id":"EnjuParser_T385","span":{"begin":128,"end":132},"obj":"CD"},{"id":"EnjuParser_T386","span":{"begin":132,"end":133},"obj":"NN"},{"id":"EnjuParser_T387","span":{"begin":133,"end":134},"obj":"-RRB-"},{"id":"EnjuParser_T388","span":{"begin":134,"end":135},"obj":"-SEMICOLON-"},{"id":"EnjuParser_T389","span":{"begin":136,"end":147},"obj":"NN"},{"id":"EnjuParser_T390","span":{"begin":147,"end":148},"obj":"-COMMA-"},{"id":"EnjuParser_T391","span":{"begin":149,"end":151},"obj":"CD"},{"id":"EnjuParser_T392","span":{"begin":152,"end":153},"obj":"-LRB-"},{"id":"EnjuParser_T393","span":{"begin":153,"end":157},"obj":"CD"},{"id":"EnjuParser_T394","span":{"begin":157,"end":158},"obj":"NN"},{"id":"EnjuParser_T395","span":{"begin":158,"end":159},"obj":"-RRB-"},{"id":"EnjuParser_T396","span":{"begin":159,"end":160},"obj":"-SEMICOLON-"},{"id":"EnjuParser_T397","span":{"begin":161,"end":173},"obj":"NN"},{"id":"EnjuParser_T398","span":{"begin":173,"end":174},"obj":"-COMMA-"},{"id":"EnjuParser_T399","span":{"begin":175,"end":177},"obj":"CD"},{"id":"EnjuParser_T400","span":{"begin":178,"end":179},"obj":"-LRB-"},{"id":"EnjuParser_T401","span":{"begin":179,"end":183},"obj":"CD"},{"id":"EnjuParser_T402","span":{"begin":183,"end":184},"obj":"NN"},{"id":"EnjuParser_T403","span":{"begin":184,"end":185},"obj":"-RRB-"},{"id":"EnjuParser_T404","span":{"begin":185,"end":186},"obj":"-RRB-"},{"id":"EnjuParser_T405","span":{"begin":187,"end":190},"obj":"CC"},{"id":"EnjuParser_T406","span":{"begin":191,"end":205},"obj":"NN"},{"id":"EnjuParser_T407","span":{"begin":206,"end":213},"obj":"NN"},{"id":"EnjuParser_T408","span":{"begin":214,"end":215},"obj":"-LRB-"},{"id":"EnjuParser_T409","span":{"begin":215,"end":217},"obj":"CD"},{"id":"EnjuParser_T410","span":{"begin":218,"end":219},"obj":"-LRB-"},{"id":"EnjuParser_T411","span":{"begin":219,"end":223},"obj":"CD"},{"id":"EnjuParser_T412","span":{"begin":223,"end":224},"obj":"NN"},{"id":"EnjuParser_T413","span":{"begin":224,"end":225},"obj":"-RRB-"},{"id":"EnjuParser_T414","span":{"begin":225,"end":226},"obj":"-RRB-"}],"relations":[{"id":"EnjuParser_R358","pred":"arg1Of","subj":"EnjuParser_T361","obj":"EnjuParser_T360"},{"id":"EnjuParser_R359","pred":"arg1Of","subj":"EnjuParser_T361","obj":"EnjuParser_T362"},{"id":"EnjuParser_R360","pred":"arg2Of","subj":"EnjuParser_T364","obj":"EnjuParser_T362"},{"id":"EnjuParser_R361","pred":"arg1Of","subj":"EnjuParser_T364","obj":"EnjuParser_T363"},{"id":"EnjuParser_R362","pred":"arg1Of","subj":"EnjuParser_T364","obj":"EnjuParser_T365"},{"id":"EnjuParser_R363","pred":"arg2Of","subj":"EnjuParser_T366","obj":"EnjuParser_T365"},{"id":"EnjuParser_R364","pred":"arg3Of","subj":"EnjuParser_T373","obj":"EnjuParser_T365"},{"id":"EnjuParser_R365","pred":"arg1Of","subj":"EnjuParser_T366","obj":"EnjuParser_T367"},{"id":"EnjuParser_R366","pred":"arg2Of","subj":"EnjuParser_T368","obj":"EnjuParser_T367"},{"id":"EnjuParser_R367","pred":"arg1Of","subj":"EnjuParser_T368","obj":"EnjuParser_T369"},{"id":"EnjuParser_R368","pred":"arg2Of","subj":"EnjuParser_T371","obj":"EnjuParser_T369"},{"id":"EnjuParser_R369","pred":"arg3Of","subj":"EnjuParser_T372","obj":"EnjuParser_T369"},{"id":"EnjuParser_R370","pred":"arg1Of","subj":"EnjuParser_T371","obj":"EnjuParser_T370"},{"id":"EnjuParser_R371","pred":"arg1Of","subj":"EnjuParser_T375","obj":"EnjuParser_T374"},{"id":"EnjuParser_R372","pred":"arg1Of","subj":"EnjuParser_T362","obj":"EnjuParser_T375"},{"id":"EnjuParser_R373","pred":"arg2Of","subj":"EnjuParser_T377","obj":"EnjuParser_T375"},{"id":"EnjuParser_R374","pred":"arg1Of","subj":"EnjuParser_T376","obj":"EnjuParser_T377"},{"id":"EnjuParser_R375","pred":"arg2Of","subj":"EnjuParser_T405","obj":"EnjuParser_T377"},{"id":"EnjuParser_R376","pred":"arg1Of","subj":"EnjuParser_T379","obj":"EnjuParser_T378"},{"id":"EnjuParser_R377","pred":"arg1Of","subj":"EnjuParser_T379","obj":"EnjuParser_T380"},{"id":"EnjuParser_R378","pred":"arg2Of","subj":"EnjuParser_T381","obj":"EnjuParser_T380"},{"id":"EnjuParser_R379","pred":"arg3Of","subj":"EnjuParser_T404","obj":"EnjuParser_T380"},{"id":"EnjuParser_R380","pred":"arg1Of","subj":"EnjuParser_T381","obj":"EnjuParser_T382"},{"id":"EnjuParser_R381","pred":"arg2Of","subj":"EnjuParser_T383","obj":"EnjuParser_T382"},{"id":"EnjuParser_R382","pred":"arg1Of","subj":"EnjuParser_T383","obj":"EnjuParser_T384"},{"id":"EnjuParser_R383","pred":"arg2Of","subj":"EnjuParser_T386","obj":"EnjuParser_T384"},{"id":"EnjuParser_R384","pred":"arg3Of","subj":"EnjuParser_T387","obj":"EnjuParser_T384"},{"id":"EnjuParser_R385","pred":"arg1Of","subj":"EnjuParser_T386","obj":"EnjuParser_T385"},{"id":"EnjuParser_R386","pred":"arg1Of","subj":"EnjuParser_T381","obj":"EnjuParser_T388"},{"id":"EnjuParser_R387","pred":"arg2Of","subj":"EnjuParser_T389","obj":"EnjuParser_T388"},{"id":"EnjuParser_R388","pred":"arg1Of","subj":"EnjuParser_T389","obj":"EnjuParser_T390"},{"id":"EnjuParser_R389","pred":"arg2Of","subj":"EnjuParser_T391","obj":"EnjuParser_T390"},{"id":"EnjuParser_R390","pred":"arg1Of","subj":"EnjuParser_T391","obj":"EnjuParser_T392"},{"id":"EnjuParser_R391","pred":"arg2Of","subj":"EnjuParser_T394","obj":"EnjuParser_T392"},{"id":"EnjuParser_R392","pred":"arg3Of","subj":"EnjuParser_T395","obj":"EnjuParser_T392"},{"id":"EnjuParser_R393","pred":"arg1Of","subj":"EnjuParser_T394","obj":"EnjuParser_T393"},{"id":"EnjuParser_R394","pred":"arg1Of","subj":"EnjuParser_T381","obj":"EnjuParser_T396"},{"id":"EnjuParser_R395","pred":"arg2Of","subj":"EnjuParser_T397","obj":"EnjuParser_T396"},{"id":"EnjuParser_R396","pred":"arg1Of","subj":"EnjuParser_T397","obj":"EnjuParser_T398"},{"id":"EnjuParser_R397","pred":"arg2Of","subj":"EnjuParser_T399","obj":"EnjuParser_T398"},{"id":"EnjuParser_R398","pred":"arg1Of","subj":"EnjuParser_T399","obj":"EnjuParser_T400"},{"id":"EnjuParser_R399","pred":"arg2Of","subj":"EnjuParser_T402","obj":"EnjuParser_T400"},{"id":"EnjuParser_R400","pred":"arg3Of","subj":"EnjuParser_T403","obj":"EnjuParser_T400"},{"id":"EnjuParser_R401","pred":"arg1Of","subj":"EnjuParser_T402","obj":"EnjuParser_T401"},{"id":"EnjuParser_R402","pred":"arg1Of","subj":"EnjuParser_T379","obj":"EnjuParser_T405"},{"id":"EnjuParser_R403","pred":"arg2Of","subj":"EnjuParser_T407","obj":"EnjuParser_T405"},{"id":"EnjuParser_R404","pred":"arg1Of","subj":"EnjuParser_T407","obj":"EnjuParser_T406"},{"id":"EnjuParser_R405","pred":"arg1Of","subj":"EnjuParser_T407","obj":"EnjuParser_T408"},{"id":"EnjuParser_R406","pred":"arg2Of","subj":"EnjuParser_T409","obj":"EnjuParser_T408"},{"id":"EnjuParser_R407","pred":"arg3Of","subj":"EnjuParser_T414","obj":"EnjuParser_T408"},{"id":"EnjuParser_R408","pred":"arg1Of","subj":"EnjuParser_T409","obj":"EnjuParser_T410"},{"id":"EnjuParser_R409","pred":"arg2Of","subj":"EnjuParser_T412","obj":"EnjuParser_T410"},{"id":"EnjuParser_R410","pred":"arg3Of","subj":"EnjuParser_T413","obj":"EnjuParser_T410"},{"id":"EnjuParser_R411","pred":"arg1Of","subj":"EnjuParser_T412","obj":"EnjuParser_T411"}],"text":"Most patients received antiviral therapy (oseltamivir, 124 [89.9%]), and many received antibacterial therapy (moxifloxacin, 89 [64.4%]; ceftriaxone, 34 [24.6%]; azithromycin, 25 [18.1%]) and glucocorticoid therapy (62 [44.9%])."}

{"project":"LitCovid-ArguminSci","denotations":[{"id":"T11","span":{"begin":0,"end":227},"obj":"DRI_Background"}],"text":"Most patients received antiviral therapy (oseltamivir, 124 [89.9%]), and many received antibacterial therapy (moxifloxacin, 89 [64.4%]; ceftriaxone, 34 [24.6%]; azithromycin, 25 [18.1%]) and glucocorticoid therapy (62 [44.9%])."}

{"project":"LitCovid-OGER","denotations":[{"id":"T2","span":{"begin":42,"end":53},"obj":"CHEBI:7798"},{"id":"T3","span":{"begin":110,"end":122},"obj":"CHEBI:63611"},{"id":"T4","span":{"begin":136,"end":147},"obj":"CHEBI:29007"},{"id":"T5","span":{"begin":161,"end":173},"obj":"CHEBI:2955"},{"id":"T6","span":{"begin":191,"end":205},"obj":"CHEBI:24261"}],"namespaces":[{"prefix":"PR","uri":"http://purl.obolibrary.org/obo/PR_"},{"prefix":"UBERON","uri":"http://purl.obolibrary.org/obo/UBERON_"}],"text":"Most patients received antiviral therapy (oseltamivir, 124 [89.9%]), and many received antibacterial therapy (moxifloxacin, 89 [64.4%]; ceftriaxone, 34 [24.6%]; azithromycin, 25 [18.1%]) and glucocorticoid therapy (62 [44.9%])."}

{"project":"LitCovid-PubTatorCentral","denotations":[{"id":"T26","span":{"begin":5,"end":13},"obj":"Species:9606"},{"id":"T27","span":{"begin":42,"end":53},"obj":"Chemical:MESH:D053139"},{"id":"T28","span":{"begin":110,"end":122},"obj":"Chemical:MESH:C104727"},{"id":"T29","span":{"begin":136,"end":147},"obj":"Chemical:MESH:D002443"},{"id":"T30","span":{"begin":161,"end":173},"obj":"Chemical:MESH:D017963"}],"text":"Most patients received antiviral therapy (oseltamivir, 124 [89.9%]), and many received antibacterial therapy (moxifloxacin, 89 [64.4%]; ceftriaxone, 34 [24.6%]; azithromycin, 25 [18.1%]) and glucocorticoid therapy (62 [44.9%])."}

{"project":"LitCovid-sentences-v1","denotations":[{"id":"TextSentencer_T21","span":{"begin":0,"end":227},"obj":"Sentence"}],"text":"Most patients received antiviral therapy (oseltamivir, 124 [89.9%]), and many received antibacterial therapy (moxifloxacin, 89 [64.4%]; ceftriaxone, 34 [24.6%]; azithromycin, 25 [18.1%]) and glucocorticoid therapy (62 [44.9%])."}

{"project":"LitCovid-TimeML","denotations":[{"id":"tok421","span":{"begin":0,"end":4},"obj":"JJS"},{"id":"tok422","span":{"begin":5,"end":13},"obj":"NNS"},{"id":"tok423","span":{"begin":14,"end":22},"obj":"VBD"},{"id":"tok424","span":{"begin":23,"end":32},"obj":"JJ"},{"id":"tok425","span":{"begin":33,"end":40},"obj":"NN"},{"id":"tok426","span":{"begin":41,"end":42},"obj":"("},{"id":"tok427","span":{"begin":42,"end":53},"obj":"NN"},{"id":"tok428","span":{"begin":53,"end":54},"obj":","},{"id":"tok429","span":{"begin":55,"end":58},"obj":"CD"},{"id":"tok430","span":{"begin":59,"end":60},"obj":"NN"},{"id":"tok431","span":{"begin":60,"end":62},"obj":"CD"},{"id":"tok432","span":{"begin":62,"end":63},"obj":"."},{"id":"tok433","span":{"begin":63,"end":64},"obj":"CD"},{"id":"tok434","span":{"begin":64,"end":65},"obj":"NN"},{"id":"tok435","span":{"begin":65,"end":66},"obj":"NN"},{"id":"tok436","span":{"begin":66,"end":67},"obj":")"},{"id":"tok437","span":{"begin":67,"end":68},"obj":","},{"id":"tok438","span":{"begin":69,"end":72},"obj":"CC"},{"id":"tok439","span":{"begin":73,"end":77},"obj":"JJ"},{"id":"tok440","span":{"begin":78,"end":86},"obj":"JJ"},{"id":"tok441","span":{"begin":87,"end":100},"obj":"NN"},{"id":"tok442","span":{"begin":101,"end":108},"obj":"NN"},{"id":"tok443","span":{"begin":109,"end":110},"obj":"("},{"id":"tok444","span":{"begin":110,"end":122},"obj":"NN"},{"id":"tok445","span":{"begin":122,"end":123},"obj":","},{"id":"tok446","span":{"begin":124,"end":126},"obj":"CD"},{"id":"tok447","span":{"begin":127,"end":128},"obj":"NN"},{"id":"tok448","span":{"begin":128,"end":130},"obj":"CD"},{"id":"tok449","span":{"begin":130,"end":131},"obj":"."},{"id":"tok450","span":{"begin":131,"end":132},"obj":"CD"},{"id":"tok451","span":{"begin":132,"end":133},"obj":"NN"},{"id":"tok452","span":{"begin":133,"end":134},"obj":"NN"},{"id":"tok453","span":{"begin":134,"end":135},"obj":":"},{"id":"tok454","span":{"begin":136,"end":147},"obj":"NN"},{"id":"tok455","span":{"begin":147,"end":148},"obj":","},{"id":"tok456","span":{"begin":149,"end":151},"obj":"CD"},{"id":"tok457","span":{"begin":152,"end":153},"obj":"NN"},{"id":"tok458","span":{"begin":153,"end":155},"obj":"CD"},{"id":"tok459","span":{"begin":155,"end":156},"obj":"."},{"id":"tok460","span":{"begin":156,"end":157},"obj":"CD"},{"id":"tok461","span":{"begin":157,"end":158},"obj":"NN"},{"id":"tok462","span":{"begin":158,"end":159},"obj":"NN"},{"id":"tok463","span":{"begin":159,"end":160},"obj":":"},{"id":"tok464","span":{"begin":161,"end":173},"obj":"NN"},{"id":"tok465","span":{"begin":173,"end":174},"obj":","},{"id":"tok466","span":{"begin":175,"end":177},"obj":"CD"},{"id":"tok467","span":{"begin":178,"end":179},"obj":"NN"},{"id":"tok468","span":{"begin":179,"end":181},"obj":"CD"},{"id":"tok469","span":{"begin":181,"end":182},"obj":"."},{"id":"tok470","span":{"begin":182,"end":183},"obj":"CD"},{"id":"tok471","span":{"begin":183,"end":184},"obj":"NN"},{"id":"tok472","span":{"begin":184,"end":185},"obj":"NN"},{"id":"tok473","span":{"begin":185,"end":186},"obj":")"},{"id":"tok474","span":{"begin":187,"end":190},"obj":"CC"},{"id":"tok475","span":{"begin":191,"end":205},"obj":"NN"},{"id":"tok476","span":{"begin":206,"end":213},"obj":"NN"},{"id":"tok477","span":{"begin":214,"end":215},"obj":"("},{"id":"tok478","span":{"begin":215,"end":217},"obj":"CD"},{"id":"tok479","span":{"begin":218,"end":219},"obj":"NN"},{"id":"tok480","span":{"begin":219,"end":221},"obj":"CD"},{"id":"tok481","span":{"begin":221,"end":222},"obj":"."},{"id":"tok482","span":{"begin":222,"end":223},"obj":"CD"},{"id":"tok483","span":{"begin":223,"end":224},"obj":"NN"},{"id":"tok484","span":{"begin":224,"end":225},"obj":"NN"},{"id":"tok485","span":{"begin":225,"end":226},"obj":")"},{"id":"tok486","span":{"begin":226,"end":227},"obj":"."},{"id":"lookup49","span":{"begin":64,"end":65},"obj":"percent"},{"id":"lookup50","span":{"begin":132,"end":133},"obj":"percent"},{"id":"lookup51","span":{"begin":157,"end":158},"obj":"percent"},{"id":"lookup52","span":{"begin":183,"end":184},"obj":"percent"},{"id":"lookup53","span":{"begin":223,"end":224},"obj":"percent"},{"id":"event14","span":{"begin":14,"end":22},"obj":"OCCURRENCE"}],"text":"Most patients received antiviral therapy (oseltamivir, 124 [89.9%]), and many received antibacterial therapy (moxifloxacin, 89 [64.4%]; ceftriaxone, 34 [24.6%]; azithromycin, 25 [18.1%]) and glucocorticoid therapy (62 [44.9%])."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T9","span":{"begin":149,"end":151},"obj":"http://purl.obolibrary.org/obo/CLO_0001302"}],"text":"Most patients received antiviral therapy (oseltamivir, 124 [89.9%]), and many received antibacterial therapy (moxifloxacin, 89 [64.4%]; ceftriaxone, 34 [24.6%]; azithromycin, 25 [18.1%]) and glucocorticoid therapy (62 [44.9%])."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T2","span":{"begin":23,"end":32},"obj":"Chemical"},{"id":"T3","span":{"begin":42,"end":53},"obj":"Chemical"},{"id":"T4","span":{"begin":110,"end":122},"obj":"Chemical"},{"id":"T5","span":{"begin":136,"end":147},"obj":"Chemical"},{"id":"T6","span":{"begin":161,"end":173},"obj":"Chemical"},{"id":"T7","span":{"begin":191,"end":205},"obj":"Chemical"}],"attributes":[{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"},{"id":"A3","pred":"chebi_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_7798"},{"id":"A4","pred":"chebi_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_63611"},{"id":"A5","pred":"chebi_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/CHEBI_29007"},{"id":"A6","pred":"chebi_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/CHEBI_2955"},{"id":"A7","pred":"chebi_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_24261"}],"text":"Most patients received antiviral therapy (oseltamivir, 124 [89.9%]), and many received antibacterial therapy (moxifloxacin, 89 [64.4%]; ceftriaxone, 34 [24.6%]; azithromycin, 25 [18.1%]) and glucocorticoid therapy (62 [44.9%])."}

{"project":"MeasurableQuantitativeAnnotation","denotations":[{"id":"E1","span":{"begin":23,"end":40},"obj":"entity"},{"id":"E2","span":{"begin":42,"end":53},"obj":"entity"},{"id":"E3","span":{"begin":87,"end":108},"obj":"entity"},{"id":"E4","span":{"begin":110,"end":122},"obj":"entity"},{"id":"N1","span":{"begin":55,"end":58},"obj":"num"},{"id":"N2","span":{"begin":60,"end":64},"obj":"num"},{"id":"N3","span":{"begin":124,"end":126},"obj":"num"},{"id":"N4","span":{"begin":128,"end":132},"obj":"num"},{"id":"U1","span":{"begin":64,"end":65},"obj":"unit"},{"id":"U2","span":{"begin":132,"end":133},"obj":"unit"},{"id":"E1","span":{"begin":136,"end":147},"obj":"entity"},{"id":"N1","span":{"begin":149,"end":151},"obj":"num"},{"id":"N2","span":{"begin":153,"end":157},"obj":"num"},{"id":"U1","span":{"begin":157,"end":158},"obj":"unit"},{"id":"E1","span":{"begin":161,"end":173},"obj":"entity"},{"id":"E2","span":{"begin":191,"end":213},"obj":"entity"},{"id":"N1","span":{"begin":175,"end":177},"obj":"num"},{"id":"N2","span":{"begin":179,"end":183},"obj":"num"},{"id":"N3","span":{"begin":215,"end":217},"obj":"num"},{"id":"N4","span":{"begin":219,"end":223},"obj":"num"},{"id":"U1","span":{"begin":183,"end":184},"obj":"unit"},{"id":"U2","span":{"begin":223,"end":224},"obj":"unit"}],"text":"Most patients received antiviral therapy (oseltamivir, 124 [89.9%]), and many received antibacterial therapy (moxifloxacin, 89 [64.4%]; ceftriaxone, 34 [24.6%]; azithromycin, 25 [18.1%]) and glucocorticoid therapy (62 [44.9%])."}

{"project":"LitCovid-PubTator","denotations":[{"id":"73","span":{"begin":5,"end":13},"obj":"Species"},{"id":"74","span":{"begin":42,"end":53},"obj":"Chemical"},{"id":"75","span":{"begin":110,"end":122},"obj":"Chemical"},{"id":"76","span":{"begin":136,"end":147},"obj":"Chemical"},{"id":"77","span":{"begin":161,"end":173},"obj":"Chemical"}],"attributes":[{"id":"A73","pred":"tao:has_database_id","subj":"73","obj":"Tax:9606"},{"id":"A74","pred":"tao:has_database_id","subj":"74","obj":"MESH:D053139"},{"id":"A75","pred":"tao:has_database_id","subj":"75","obj":"MESH:D000077266"},{"id":"A76","pred":"tao:has_database_id","subj":"76","obj":"MESH:D002443"},{"id":"A77","pred":"tao:has_database_id","subj":"77","obj":"MESH:D017963"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Most patients received antiviral therapy (oseltamivir, 124 [89.9%]), and many received antibacterial therapy (moxifloxacin, 89 [64.4%]; ceftriaxone, 34 [24.6%]; azithromycin, 25 [18.1%]) and glucocorticoid therapy (62 [44.9%])."}

{"project":"LitCovid-sentences","denotations":[{"id":"T21","span":{"begin":0,"end":227},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Most patients received antiviral therapy (oseltamivir, 124 [89.9%]), and many received antibacterial therapy (moxifloxacin, 89 [64.4%]; ceftriaxone, 34 [24.6%]; azithromycin, 25 [18.1%]) and glucocorticoid therapy (62 [44.9%])."}